Nature Biotechnology Impact Factor, Indexing, Ranking

Nature Biotechnology Impact Factor, Indexing, Ranking

Nature Biotechnology (NB) is a scholarly journal dedicated to publishing research in the field of Immunology and Microbiology, and Published by Nature Publishing. The Print-ISSN to Nature Biotechnology is 1087-0156 and its abbreviation is Nat Biotechnol.


Nature Biotechnology Aim and Scope

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences as well as covers the commercial, political, ethical, legal, and societal aspects of this research. The first function is fulfilled by the peer-reviewed research section, the second by the expository efforts in the front of the journal. We provide researchers with news about business; we provide the business community with news about research developments.

The core areas in which we are actively seeking research papers include: molecular engineering of nucleic acids and proteins; molecular therapy (therapeutics genes, antisense, siRNAs, aptamers, DNAzymes, ribozymes, peptides, proteins); large-scale biology (genomics, functional genomics, proteomics, structural genomics, metabolomics, etc.); computational biology (algorithms and modeling), regenerative medicine (stem cells, tissue engineering, biomaterials); imaging technology; analytical biotechnology (sensors/detectors for analytes/macromolecules), applied immunology (antibody engineering, xenotransplantation, T-cell therapies); food and agricultural biotechnology; and environmental biotechnology. A comprehensive list of areas of interest is shown below.

Genetic engineering

Strategies for controlling gene expression Strategies for manipulating gene structure Strategies for gene containment

Large-scale approaches

Technologies for analyzing gene function (e.g., arrays, SAGE) Technologies for analyzing gene structure/organization (e.g., molecular beacons) Chemogenomics or chemical genetics Pharmacogenomics/SNPs Computational analysis

Proteomics

Technologies for analyzing/identifying protein structure/function (e.g., 2-D gels, mass spectrometry, yeast two-hybrid, SPR, NMR, arrays and chips) Structural genomics Computational analysis

Metabolomics

Technologies for analyzing/profiling metabolites (chromatography, mass spectrometry) Computational analysis

Computational biology

Bioinformatics; algorithms; data deconvolution Modeling and systems biology: kinetics-based models and constraints-based models

Molecular engineering

Rational approaches for proteins/antibodies/enzymes/drugs Molecular evolution Molecular breeding approaches

Metabolic engineering

Genetic manipulation of species of interest to modify or allow the production of a commercially or therapeutically relevant compound Computational analysis

Novel expression systems

Mammalian cells Insect cells Bacteria Fungi Plant cells

Delivery of genes, drugs, or cells

Targeting strategies Viral and nonviral vector strategies

Imaging

Reporter molecules Imaging approaches/technologies for visualizing whole animals, cells, or single molecules Computational analysis

Nucleic acid therapeutics

Gene therapy (targeting, expression, integration, immunogenicity) Antisense RNAi DNAzymes and ribozymes Other (e.g., chimeric oligonucleotides/triple helix)

Nanobiotechnology

Nanomaterials for use in drug delivery or as therapeutics Nanomaterials for use in industrial biotechnology Nanosensors Nanosystems for imaging molecules and cells

Vaccines and applied immunology

Antibody engineering T-cell therapies Therapies exploiting innate immunity (e.g. complement) Antigen delivery vectors and approaches Nucleic acid vaccines Computational analysis

Regenerative medicine

Stem cells Tissue engineering Therapeutic cloning (somatic cell nuclear transfer) Xenotransplantation Biomaterials

Biosensors

Approaches for detecting biological molecules Use of biological systems in detecting analytes

Assay systems

Approaches for multiplexing and increasing throughput Selection/screening strategies for gene/proteins/drugs Microfluidics

Biomaterials

Engineering materials for biological application Molecular imprinting Biomimetics Nanotechnology

Agbiotech and transgenic plants

Crop improvement (resistance to stress, disease, pests) Nutraceuticals Forest biotechnology Plant vaccines Plants as bioreactors Gene-containment strategies

Pharming

Transgenic animals Knockouts Reproductive cloning Biopharmaceutical and enzyme production Transgene targeting and expression strategies

Environmental

Bioremediation Biomining Phytoremediation Monitoring


Nature Biotechnology Details


Journal title Nature Biotechnology (NB)
Abbreviation Nat Biotechnol
Print ISSN 1087-0156
Online ISSN 1546-1696
Publisher Name Nature Publishing
Editor-in-chief Barbara Cheifet
Subject Category Immunology and Microbiology
Impact Factor 68.164
SJR 22.781
Ranking 18
CiteScore 71.9
H-Index 491
Status 🟢 Active
Impact Factor List 2024

Who we are? Clarification: Journals Insights - Your Open Access Ally